Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose magnesium sulphate versus Pritchard regimen for severe preeclampsia and eclampsia
PACTR202508772932490Not yet recruiting
- Sponsor
- Self
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of magnesium sulfate in preeclampsia and eclampsia (2 arms), sponsored by Self. Primary endpoints: Occurrence of seizures and Recurrence of seizures. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
preeclampsiaeclampsia
Beyond the preview
Go deeper on PACTR202508772932490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202508772932490.